Fierce Pharma
MAY 23, 2023
Amid high-profile injectable launch, Novo Nordisk scores with its pill version of obesity drug Wegovy kdunleavy Tue, 05/23/2023 - 10:34
Dominic Tyer
MAY 23, 2023
On Wednesday 24 May I’ll be discussing recent DT Consulting research on how to best engage HCPs over digital and non-digital channels and what content experiences best connect with them
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
MAY 23, 2023
The clock's ticking on Stelara: Amgen, J&J ink patent settlement esagonowsky Tue, 05/23/2023 - 17:08
MedCity News
MAY 23, 2023
A panel during the MedCity News INVEST conference discussed what digital health technologies need to do to demonstrate return on investment for payers, providers, and other stakeholders.
Fierce Pharma
MAY 23, 2023
ASCO: Bristol Myers' $4B plan for Reblozyl takes shape in blood cancer anemia—with one caveat aliu Tue, 05/23/2023 - 17:18
European Pharmaceutical Review
MAY 23, 2023
New research by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20 percent of European biotech companies are now headquartered in Switzerland. Sixty three out of a total of 265 companies settling in Switzerland were biotechs. This makes it the second most important sector after ICT, the research found. 2022 statistics by the Swiss federal government confirm that the trend to base here is continuing.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
MAY 23, 2023
Yaniv Sneor, the co-founder of Mid Atlantic Bio Angels and part of the Ask the Investor sessions at MedCity INVEST this week, explained what his firm looks for in life science startups.
Pharmaceutical Technology
MAY 23, 2023
Avrobio has announced a deal to sell its investigational haematopoietic stem cell (HSC) gene therapy programme , designed to treat cystinosis, to Novartis in an all-cash deal valued at $87.5m. Novartis will receive an exclusive licence for intellectual property related to the gene therapy platform of Avrobio for use in cystinosis and for other assets.
MedCity News
MAY 23, 2023
The quest to enact local bans has become particularly acute in small towns, like West Wendover, Nevada, and Hobbs, New Mexico, which are situated by borders between states that have restricted abortion and states where laws preserve access.
Pharmaceutical Technology
MAY 23, 2023
The US Food and Drug Administration (FDA) has granted approval for Blueprint Medicines’ Ayvakit (avapritinib) as the first and only treatment for indolent systemic mastocytosis (ISM) in adult patients. The precision therapy has been designed for potently and selectively inhibiting KIT D816V, which is the main underlying driver of the disease. It received FDA approval to treat ISM, advanced SM, including SM with an associated haematological neoplasm (SM-AHN) and mast cell leukemia (MCL), and aggr
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
MAY 23, 2023
It shouldn’t be so hard for Americans to access healthy foods, said Dr. Elizabeth Klodas, founder of healthy food company Step One Foods, during a Tuesday panel at the MedCity INVEST conference in Chicago. There should be incentives for food companies and better nutrition education for Americans.
LEVO Health
MAY 23, 2023
In the dynamic world of healthcare marketing, understanding your audience and optimizing your strategies are key to staying ahead of the competition. Practices can use healthcare data analytics to gain insights that can transform their marketing efforts in the digital age. Data analytics is the process of collecting and analyzing data to make informed decisions.
MedCity News
MAY 23, 2023
During MedCity News’ INVEST conference, CommonSpirit Health CIO Daniel Barchi laid out two critical actions that hospitals can take to help ensure their new technology investments will be worth their time and money. The first is to prioritize scalability, and the second is to involve frontline clinical staff early on in the process.
Pharmaceutical Technology
MAY 23, 2023
Croda Pharma has entered a strategic collaboration deal with Botanical Solution Inc (BSI) to expedite the production of sustainable pharmaceutical-grade vaccine adjuvant QS-21. QS-21 is a potent component of adjuvant systems used in vaccines for diseases such as RSV, malaria and shingles, as well as in new vaccines and immunotherapy treatments such as cancer.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Medgadget
MAY 23, 2023
Researchers at the University of Göttingen in Germany have developed a cell culture chamber that lets them culture tissue samples, mimic the mechanical conditions that tissues experience in various disease states, and closely monitor tissue reactions. The technology could be particularly useful for pre-clinical drug testing, allowing researchers to test the effects of various drug candidates on tissues without the need to use experimental animals.
PharmaVoice
MAY 23, 2023
Ancient DNA from a deer tooth. A new way to connect genes with disease. Biological super-computing. These genetic advances could play a part in our biopharma future.
European Pharmaceutical Review
MAY 23, 2023
Using inkjet printing, optimised machine learning (ML) models predicted the printability of drug formulations with an accuracy of 97.22 percent, a paper published in International Journal of Pharmaceutics: X has shown. Inkjet printing makes formulation and printing parameter optimisation time-consuming. This is especially true for additive manufacturing and the production of unique dosage forms and personalised medicines.
Medgadget
MAY 23, 2023
A recent study in Nature Medicine , entitled “ An automated histological classification system for precision diagnostics of kidney allografts ,” has showcased the efforts of a group of researchers who have developed an automated system that can diagnose kidney transplant rejection. A variety of disparate factors can affect the chances that a transplant will be rejected.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Copyright Clearance Center
MAY 23, 2023
The post Iraqi Publisher Wins IPA’s Prix Voltaire, Slain Ukrainian Author Honored appeared first on Copyright Clearance Center.
MedCity News
MAY 23, 2023
As pharmaceutical reps are used less and less, the role of the MSL has become more prominent as a conduit between life sciences companies and external stakeholders for drug development.
MedReps
MAY 23, 2023
Preparing to apply for medical sales jobs requires more than just an updated resume and a detailed cover letter. You also need a number of different tools in order to successfully interview for jobs and stay organized so you don’t miss out on submitting an assessment on time. Thankfully, many of these tools are inexpensive or even free, making them even better for assisting you with your job hunt.
MedCity News
MAY 23, 2023
We live in a world in which the patient is empowered like never before.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Medgadget
MAY 23, 2023
Researchers at Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland have developed a soft robotic electrode, that can be advanced through a small hole in the skull and then opened into a series of spiral arms, to provide electrocorticography measurements from a relatively large area of the brain surface. The technology could prove very useful for brain surgeons who wish to map regions of the brain that may be triggering epileptic seizures and then target these lesions surgically.
PharmaTimes
MAY 23, 2023
Receptor antagonist AM1476 developed as an anti-fibrotic treatment for lung and skin disorders
Pharmaceutical Technology
MAY 23, 2023
ReNAgade Therapeutics has burst onto the RNA technology scene by announcing a $300m financing round. As per the company, the round, led by MPM BioImpact and F2 Ventures, is the largest Series A funding round of 2023. Founded by MPM BioImpact, ReNAgade’s portfolio includes novel lipid nanoparticles (LNPs). With its delivery system, Cambridge, Massachusetts-based biotech says it aims to “address major limitations in RNA therapeutics by enabling the delivery of RNA medicines to previously inaccessi
PharmaTimes
MAY 23, 2023
Vital financing will allow the company to build a pipeline of novel therapies targeting serious conditions
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Scott Burrows
MAY 23, 2023
How Can We Not Feel Pride in Texas? “Optimism isn’t just a state of mind, it’s a practice. But seizing an opportunity to improve things can rarely be done alone. Texans work together every day to help their neighbors, respond to disaster, and build brighter futures.
PharmaTech
MAY 23, 2023
With $73 million in financing from investment firms, Myeloid Therapeutics plans to accelerate its lead clinical candidate into Phase I/II development for treating solid tumors.
Evolve Your Success
MAY 23, 2023
Virtual reality is not just a game-changer for medical sales, but a life-changer for all of us. It’s a tool that allows us to practice, learn, and grow in ways we never thought possible. And the potential for its impact on our world is limitless. In this episode, Samuel Adeyinka interviews David Howe to explore the world of virtual reality training for medical device sales reps.
Pharmaceutical Technology
MAY 23, 2023
The global pharmaceutical industry experienced a 23% decline in the number of environmental sustainability-related patent applications in Q1 2023 compared with the previous quarter. The total number of environmental sustainability-related grants dropped by 24% in Q1 2023, according to GlobalData’s Patent Analytics. With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate sustainability with suppliers playing a crucial role in the process.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
234 
Let's personalize your content